BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 31547621)

  • 1. Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury.
    Jiménez-Castro MB; Cornide-Petronio ME; Gracia-Sancho J; Peralta C
    Cells; 2019 Sep; 8(10):. PubMed ID: 31547621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update.
    Gracia-Sancho J; Casillas-Ramírez A; Peralta C
    Clin Sci (Lond); 2015 Aug; 129(4):345-62. PubMed ID: 26014222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models.
    Datta G; Fuller BJ; Davidson BR
    World J Gastroenterol; 2013 Mar; 19(11):1683-98. PubMed ID: 23555157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.
    Ellett JD; Evans ZP; Atkinson C; Schmidt MG; Schnellmann RG; Chavin KD
    Liver Transpl; 2009 Sep; 15(9):1101-9. PubMed ID: 19718644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Polarization and Liver Ischemia-Reperfusion Injury.
    Wang H; Xi Z; Deng L; Pan Y; He K; Xia Q
    Int J Med Sci; 2021; 18(5):1104-1113. PubMed ID: 33526969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocytokines in Steatotic Liver Surgery/Transplantation.
    Jiménez-Castro MB; Casillas-Ramírez A; Negrete-Sánchez E; Avalos-de León CG; Gracia-Sancho J; Peralta C
    Transplantation; 2019 Jan; 103(1):71-77. PubMed ID: 30586349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.
    Neri AA; Dontas IA; Iliopoulos DC; Karatzas T
    In Vivo; 2020; 34(3):953-964. PubMed ID: 32354880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ischemia-reperfusion syndrome associated with liver transplantation: an update].
    Casillas-Ramírez A; Mosbah IB; Franco-Gou R; Rimola A; Roselló-Catafau J; Peralta C
    Gastroenterol Hepatol; 2006 May; 29(5):306-13. PubMed ID: 16733038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic ischemia reperfusion injury: Contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly.
    Teoh NC
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():180-7. PubMed ID: 21199530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindin deficiency protects the liver against ischemia/reperfusion injury.
    Sun P; Zhang P; Wang PX; Zhu LH; Du Y; Tian S; Zhu X; Li H
    J Hepatol; 2015 Nov; 63(5):1198-211. PubMed ID: 26165142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver.
    Kadono K; Kageyama S; Nakamura K; Hirao H; Ito T; Kojima H; Dery KJ; Li X; Kupiec-Weglinski JW
    J Hepatol; 2022 Apr; 76(4):896-909. PubMed ID: 34871625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery.
    Tashiro H; Kuroda S; Mikuriya Y; Ohdan H
    Surg Today; 2014 Sep; 44(9):1611-25. PubMed ID: 24078000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver.
    Sikalias N; Karatzas T; Alexiou K; Mountzalia L; Demonakou M; Kostakis ID; Zacharioudaki A; Papalois A; Kouraklis G
    J Invest Surg; 2018 Oct; 31(5):366-377. PubMed ID: 28644700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokines in pharmacological modulation of hepatic ischemia/reperfusion injury.
    Husted TL; Lentsch AB
    Curr Pharm Des; 2006; 12(23):2867-73. PubMed ID: 16918417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.
    Liu A; Fang H; Dirsch O; Jin H; Dahmen U
    Cytokine; 2012 Jan; 57(1):150-7. PubMed ID: 22136975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
    Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
    Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Palumbo T; Nakamura K; Lassman C; Kidani Y; Bensinger SJ; Busuttil R; Kupiec-Weglinski J; Zarrinpar A
    Transplantation; 2017 Feb; 101(2):322-331. PubMed ID: 27820779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Adipokines in Surgical Procedures Requiring Both Liver Regeneration and Vascular Occlusion.
    Álvarez-Mercado AI; Bujaldon E; Gracia-Sancho J; Peralta C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury.
    Huang M; Cai H; Han B; Xia Y; Kong X; Gu J
    Front Immunol; 2022; 13():870038. PubMed ID: 35418990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.